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Better Differentiation Between Suprabasal Epidennolytic Skin Diseases 
Determining the molecular basis for skin diseases has added a new 
dimension for diagnosis. In this issue, three groups report on the 
specific mutation that differentiate ichthyosis bullosa of Siemens 
(IBS) from bullous congenital ichthyosiform erythroderma (BCIE) 
(also called epidermolytic hyperkeratosis, EHK). McLean et al (p. 
277) show that the gene involved in IBS is keratin K2e, not Kl or 
KI0 as in BCIE. The K2e gene is only expressed very late in differ-
entiation as the keratinocytes reach the upper nucleated layers from 
the dermo-epidermaljunction, and when it is mutated tonofilament 
aggregation in the upper suprabasal epidermal cells is found. Steijlen 
et al (p. 282) also address the question of which keratin genes are 
involved in IBS. They examine candidate genes expressed in the 
suprabasal compartment of the epidermis. In comparing skin sam-
ples from IBS and ichthyosis exfoliativa (IE) patients, they find 
cosegregation of the keratin 1 and 2e genes that cluster on chromo-
some 12 in both. Kremer et al (p. 286) further analyze IBS and IE 
skin samples. Using mutational analysis of the keratin genes, they 
find the same mutation in K2e in both IBS and IE, indicating that 
these are the same disease. IBS, an autosomal dominant skin disease 
is a form of epidermolytic ichthyosis in which subtle thickening of 
the skin occurs on the flexor and extensor aspects of the joints with a 
characteristic superficial shedding of the upper layers of the skin 
known as the Mauserung phenomenon. Histopathologically, IBS 
skin shows blistering in the upper spinous layer, a higher level than 
in BCIE. The reported mutation sites of the K2e gene in IBS show 
clustering in the highly conserved alpha helical rod domain of the 
keratin 2 molecule. These mutation cause the affected keratinocytes 
to be fragile, resulting in blistering. Until recently, differentiation 
of the epidermolytic diseases from each other was based on clinical 
and histologic examinations. Now, as these studies indicate, specific 
identification of gene mutations will allow better classification of 
these diseases, and perhaps more specific treatments. 
Migration of Thy-l Dendritic Epidermal Cells 
Using a model of skin in organ culture, Tamaki et al (p. 290) find 
that Thy-1 dendritic epidermal cells retain the potential for migra-
tion in vitro, and that leukosialin and tumor necrosis factor a 
(TFNa), a keratinocyte-derived cytokine, are partially responsible 
for the migration ofThy-l cel ls into the epidermis. Previous studies 
have shown that dendritic epidermal cells immigrate into the epi-
dermis from the circulation through several components of the skin, 
for example, endothelium, connective tissue, basement membrane, 
and keratinocytes. Recent evidence in human tissues has shown that 
cutaneous lymphocyte-associated antigen and endothelial leuko-
cyte adhesion molecule-l are important in skin homing. In mice it 
has been shown that subsets ofT cells migrate to specific tissues, but 
the mechanism is not known. In this study, using antibodies to 
several ligands, the authors determined that CD44, LFA-l, IL-1a , 
IL-6, fibronectin, and laminin do not affect Thy-l cell migration. In 
addition, they find that antibodies to a speicfic epitope ofleukosialin 
and to TNFa only partially inhibit Thy-l cell migration, suggest-
ing that other factors may be involved. 
Basic Fibroblast Growth Factor Induces Changes in Endothelial Cell Morphology 
In this issue, Sepp et al (p. 295) report that stimulating human 
dermal microvascular endothelial cells with basic fibroblast growth 
factor (bFGF) induces changes in the cell morphology that are di-
recdy related to the increase in cell-surface integrin avP3 expres-
sion. In addition, they find that these stimulatory effects of bFGF 
are inhibited by transforming growth factor P or interferon )1. Dur-
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ing wound healing, the microvascular endothelial cells in skin are 
recruited into wounded areas to form new blood vessels. Previous 
studies have shown that bFGF, a potent angiogenic agent, serves as a 
stimulus for both proliferation and migration of endothelial cells. 
Central to the endothelial cell migration is the ability of the cells to 
interact with the proteins that characterize the wound matrix. Such 
interaction occurs through a family of cell-surface adherence pro-
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teins known as integrins, with the specific integrin complex avf33 
mediating endothelial cell binding to various proteins found in the 
wound matrix. The study presented here suggests that through the 
effects on endothelial cell integrin expression, growth factors and 
p:oinflan:matory cytokines may play critical roles in regulation an-
gIOgenesIs. 
Psoriasis Update: Induced Expression of Adhesion Molecules on Endothelial Cells 
Petzelbauer et al (p. 300) report that the cytokine-response of 
ELAM-l (endothelial leukocyte adhesion molecule-1) and VCAM-
1 (vascular cell adhesion molecule-1) on the endothelial cells of the 
intrapapillary part of the capillary loop is upregulated in psoriatic 
skin lesions. The expression of cytokine-inducible leukocyte adhe-
sion molecules, such as ELAM-l and VCAM-l, by human endothe-
lial cells contributes to the recruitment of inflammatory leukocytes 
into the skin. Furthermore, the responsiveness of the endothelial 
cells to cytokines varies with anatomic position. In normal skin the 
inducible ELAM-l expression is confined to the venules of the 
horizontal plexus and the capillary loops, and VCAM-l is not ex-
pressed. In psoriasis the architecture is altered, such that the capil-
lary loops are elongated and no longer maintain well-defined 
boundaries, and both ELAM-l and VCAM-l are expressed and 
inducible. This study suggests that altered responsiveness of the 
endothelial cells in psoriatic lesions is directly related to the aberrant 
architecture of the capillary loops and that this change in pattern 
may explain the circumscribed nature and the epidermal involve-
ment in the psoriatic plaque. 
